🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and overall safety an...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01582815
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01932333
Treatments Being Tested
The purpose of this study is to explore the safety, tolerability, and poten...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01323205
Treatments Being Tested
The purpose of this study is to evaluate \[11C\] JNJ-42491293 as a PET liga...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01359852
The purpose of this study is to characterize the 5-HT2A binding over the ma...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01358006
Treatments Being Tested
The purpose of this study is to compare the rate and extent of absorption o...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01932320
The purpose of the study is to evaluate the effect of JNJ-40411813 on rapid...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01951053
Treatments Being Tested
The objective of this study is to investigate whether JNJ-40411813 versus p...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01101659
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and phar...
Status
Completed
Location
Souseikai Fukuoka Mirai Hospital
Start Date
2021-01-29
Trial ID
NCT04677530
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of up to 3 dose level...
Status
Completed
Location
Tucson Neuroscience Research
Start Date
2021-05-18
Trial ID
NCT04836559
Treatments Being Tested